<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701441</url>
  </required_header>
  <id_info>
    <org_study_id>2005H0221</org_study_id>
    <nct_id>NCT00701441</nct_id>
  </id_info>
  <brief_title>The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea</brief_title>
  <official_title>The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rami Khayat</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive Sleep Apnea (OSA) is the most common sleep disorder affecting up to 9-24 percent
      of middle aged adults, and is becoming increasingly implicated in the pathogenesis of
      hypertension, and other cardiovascular disorders. Up to half of patients with OSA have
      hypertension, and their risk of developing hypertension increases with the increasing
      severity of Sleep Apnea. Patients with OSA and no hypertension have endothelial dysfunction,
      which is believed to be the precursor for most cardiovascular disorders.

      The upper airway collapse and obstruction that occur in OSA result in a pattern of
      intermittent hypoxia, that has been shown to be the cause of the hypertension, and
      endothelial dysfunction found in patients with OSA. Intermittent hypoxia results in oxidative
      stress, which in turn is linked to the pathogenesis of hypertension and endothelial
      dysfunction.

      This protocol evaluates the role of the oxidative stress in endothelial function and blood
      pressure in patients with OSA. This is a pilot clinical study that will compare oxidative
      stress parameters, and endothelial function in patients with OSA before starting treatment
      with continuous positive airway pressure (CPAP) and 12 weeks post being on CPAP. These
      patients will be compared to control patients with no history of OSA. the study does not
      involve assignement to different treatments. All patients will receive the indicated
      treatment for OSA and measurements will be collected before and 12 weeks after adequate
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive Sleep Apnea (OSA) is increasingly recognized as a cardiovascular risk factor. OSA
      is a cause of hypertension and has strong association with atherosclerosis, coronary heart
      disease, diabetes stroke , and fatal cardiovascular events. Endothelial dysfunction is a
      preclinical vascular abnormality that predicts subsequent development of vascular disease .
      Patients with OSA demonstrate endothelial dysfunction in the absence of any manifested
      vascular disease . The mechanism of endothelial dysfunction in OSA is largely unknown.
      Endothelial dysfunction in OSA is reversible with antioxidants, suggesting a role for oxidant
      overproduction in the decreased NO availability in OSA. This provides parallels to other
      cardiovascular diseases in which oxidative stress induced endothelial dysfunction is
      important.

      Recent studies reported evidence of dysfunction or decreased expression of endothelial nitric
      oxide synthase (eNOS) in association with increased peroxynitrite in harvested venous
      endothelial cells of OSA patients. We endeavored to perform the first direct quantification
      of microvascular endothelial genes from OSA patients. We hypothesized that patients with OSA
      who are free of any cardiovascular disease will have early functional changes in the
      microcirculatory endothelial cells that are associated with OSA, and therefore would resolve
      with treatment. Given the role of oxidative stress in the vascular disease of OSA, we
      expected to find evidence of superoxide overproduction in the microcirculatory vessels. We
      expected these functional changes to be reversible with treatment of OSA.

      Measurement of superoxide will be done on the subcutaneous biopsy tissue using quantitative
      Polymerase Chain Reaction (qPCR) and immunohistochemistry techniques and image analysis
      software. Measurement of endothelial function will be done using Doppler ultrasound.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Flow Mediated Dilation</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>A non-invasive test using an ultrasound to measure baseline resting vessel diameter and vessel wall dilation in upper arm post application of an inflated blood pressure cuff for five minutes. The percentage change in vessel wall dilation due to stimulation from the resting vessel diameter will be calculated for each group of participants. The results will be compared relative to each group of participants.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Peroxynitrite Deposition in the Vascular Walls</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>A forearm biopsy will be collected to isolate human microcirculatory endothelial cells. The stain density of peroxynitrite, an indicator of oxidative stress, in the vascular walls is compared between pre-treatment and post treatment patient tissue. Also another comparison is made between pre-treatment and control tissue. The stain density is a software-generated measurement of pixel intensity and is considered to be an arbitrary unit. Higher numbers indicate greater density</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Control group: healthy individuals without OSA</arm_group_label>
    <description>healthy individuals without OSA who are matched in weight and age to the participating OSA patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OSA group</arm_group_label>
    <description>Patients in the OSA group receive CPAP for 12 weeks as part of their care. patients with OSA provide measures at baseline and after 12 weeks of CPAP treatment.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and tissue biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        People screened for sleep apnea with a completed sleep study who do not have hypertension
        or coronary artery disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Completed sleep study - Older than 18

        Exclusion Criteria:

          -  Hypertension

          -  Diabetes

          -  coronary disease

          -  Peripheral vascular disease

          -  High cholesterol

          -  Smoking

          -  Pregnancy

          -  Use of erectile dysfunction medications or supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rami Khayat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Patt BT, Jarjoura D, Haddad DN, Sen CK, Roy S, Flavahan NA, Khayat RN. Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2010 Dec 15;182(12):1540-5. doi: 10.1164/rccm.201002-0162OC. Epub 2010 Jul 23.</citation>
    <PMID>20656942</PMID>
  </results_reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2008</study_first_submitted>
  <study_first_submitted_qc>June 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <results_first_submitted>August 12, 2011</results_first_submitted>
  <results_first_submitted_qc>October 29, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 30, 2013</results_first_posted>
  <last_update_submitted>October 29, 2013</last_update_submitted>
  <last_update_submitted_qc>October 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Rami Khayat</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>sleep apnea,</keyword>
  <keyword>oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>No diagnosis of Obstructive Sleep Apnea or treatment with continuous positive airwary therapy</description>
        </group>
        <group group_id="P2">
          <title>Obstructive Sleep Apnea</title>
          <description>Participants wear continuous positive airway therapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>failure in cpap compliance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>No diagnosis of Obstructive Sleep Apnea or treatment with continuous positive airwary therapy</description>
        </group>
        <group group_id="B2">
          <title>Obstructive Sleep Apnea</title>
          <description>Participants wear continuous positive airway therapy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.2" spread="7.4"/>
                    <measurement group_id="B2" value="43.6" spread="11.2"/>
                    <measurement group_id="B3" value="39.5" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Flow Mediated Dilation</title>
        <description>A non-invasive test using an ultrasound to measure baseline resting vessel diameter and vessel wall dilation in upper arm post application of an inflated blood pressure cuff for five minutes. The percentage change in vessel wall dilation due to stimulation from the resting vessel diameter will be calculated for each group of participants. The results will be compared relative to each group of participants.</description>
        <time_frame>Baseline and 12 weeks</time_frame>
        <population>Comparative values analyzed for those with endothelial nitric oxide synthase and nitrotyrosine stain density values only.</population>
        <group_list>
          <group group_id="O1">
            <title>Obstructive Sleep Apnea-pre Treatment</title>
            <description>Participants with Obstructive Sleep Apnea prior to receiving positive airway pressure treatment</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Participants with no diagnosis of obstructive sleep apnea and no treatment with continuous positive airway pressure</description>
          </group>
          <group group_id="O3">
            <title>Obstructive Sleep Apnea Post Treatment</title>
            <description>Participants with Obstructive Sleep Apnea after receiving positive airway pressure treatment for twelve weeks(% dilation change from baseline)</description>
          </group>
        </group_list>
        <measure>
          <title>Flow Mediated Dilation</title>
          <description>A non-invasive test using an ultrasound to measure baseline resting vessel diameter and vessel wall dilation in upper arm post application of an inflated blood pressure cuff for five minutes. The percentage change in vessel wall dilation due to stimulation from the resting vessel diameter will be calculated for each group of participants. The results will be compared relative to each group of participants.</description>
          <population>Comparative values analyzed for those with endothelial nitric oxide synthase and nitrotyrosine stain density values only.</population>
          <units>percentage change of vessel diamter</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread=".5"/>
                    <measurement group_id="O2" value="9.5" spread=".6"/>
                    <measurement group_id="O3" value="7.3" spread=".9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Flow mediated dilation = [(average maximum dilation post cuff deflation - average baseline diameter)/ average baseline diameter]100</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <p_value_desc>For comparing pre versus post, paired t tests were used. We considered tests in the hypothesized direction conclusive</p_value_desc>
            <method>t-test, 2 sided</method>
            <method_desc>For each comparison, we tested at the 0.05 level with double-sided P values. We used no correction for multiple testing when declaring significance.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Peroxynitrite Deposition in the Vascular Walls</title>
        <description>A forearm biopsy will be collected to isolate human microcirculatory endothelial cells. The stain density of peroxynitrite, an indicator of oxidative stress, in the vascular walls is compared between pre-treatment and post treatment patient tissue. Also another comparison is made between pre-treatment and control tissue. The stain density is a software-generated measurement of pixel intensity and is considered to be an arbitrary unit. Higher numbers indicate greater density</description>
        <time_frame>baseline and 12 weeks</time_frame>
        <population>Comparative values analyzed for those with endothelial nitric oxide synthase and flow mediated dilation only.</population>
        <group_list>
          <group group_id="O1">
            <title>Obstructive Sleep Apnea-pre Treatment</title>
            <description>Participants with Obstructive Sleep Apnea prior to receiving positive airway pressure treatment(Stain Density Units)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Participants with no diagnosis of obstructive sleep apnea and no treatment with continuous positive airway pressure(Stain Density Units)</description>
          </group>
          <group group_id="O3">
            <title>Obstructive Sleep Apnea Post Treatment</title>
            <description>Participants with Obstructive Sleep Apnea after receiving positive airway pressure treatment for twelve weeks(Stain Density Units)</description>
          </group>
        </group_list>
        <measure>
          <title>Peroxynitrite Deposition in the Vascular Walls</title>
          <description>A forearm biopsy will be collected to isolate human microcirculatory endothelial cells. The stain density of peroxynitrite, an indicator of oxidative stress, in the vascular walls is compared between pre-treatment and post treatment patient tissue. Also another comparison is made between pre-treatment and control tissue. The stain density is a software-generated measurement of pixel intensity and is considered to be an arbitrary unit. Higher numbers indicate greater density</description>
          <population>Comparative values analyzed for those with endothelial nitric oxide synthase and flow mediated dilation only.</population>
          <units>stain density units</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.0" spread="1.6"/>
                    <measurement group_id="O2" value="21.8" spread="1.9"/>
                    <measurement group_id="O3" value="30.5" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For comparing pre- versus post-treatment, paired t tests were used. For each variable and comparison, we tested at the 0.05 level with double-sided P values.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <p_value_desc>We only consider tests in the hypothesized direction conclusive, so testing is conservative from that perspective. However, we used no correction for multiple testing when declaring significance</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>No diagnosis of Obstructive Sleep Apnea or treatment with continuous positive airwary therapy</description>
        </group>
        <group group_id="E2">
          <title>Obstructive Sleep Apnea</title>
          <description>Participants wear continuous positive airway therapy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small Feasibility trial only.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Rami Khayat</name_or_title>
      <organization>Ohio State University</organization>
      <phone>614-247-7707</phone>
      <email>rami.khayat@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

